User:Michela Jordan/Sandbox1
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
== Structural highlights == | == Structural highlights == | ||
| - | <scene name='10/1038822/Not_great/1'>space fill amino acids</scene> | ||
| - | <scene name='10/1038822/Not_great/2'>class example 2</scene> | ||
<scene name='10/1038822/Trizep_receptor_trp/4'>Tirzepatide and Receptor interaction</scene> | <scene name='10/1038822/Trizep_receptor_trp/4'>Tirzepatide and Receptor interaction</scene> | ||
| + | <scene name='10/1038822/Trizep_receptor_interaction_2/4'>Tirzepatide and Receptor interactions at the N-term of Tirzepatide</scene> | ||
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
Revision as of 13:54, 11 April 2024
Glucagon-Like Peptide 1 Receptor (GLP-1R)
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ Ransey E, Paredes E, Dey SK, Das SR, Heroux A, Macbeth MR. Crystal structure of the Entamoeba histolytica RNA lariat debranching enzyme EhDbr1 reveals a catalytic Zn(2+) /Mn(2+) heterobinucleation. FEBS Lett. 2017 Jul;591(13):2003-2010. doi: 10.1002/1873-3468.12677. Epub 2017, Jun 14. PMID:28504306 doi:http://dx.doi.org/10.1002/1873-3468.12677
- ↑ Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2012 Dec;8(12):728-42. PMID:22945360 doi:10.1038/nrendo.2012.140
